Example: Heart Attack

Clinical Trials on Gonadal Disorders

Total 3137 results

NCT04504110

Recruiting

68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings

Conditions: Epithelial Ovarian Cancer
NCT04501913

Recruiting

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Conditions: Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8; Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage 0 Gastric Cancer AJCC v8; Clinical Stage I Esophageal Adenocarcinoma AJCC v8; Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage I Gastric Cancer AJCC v8; Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage II Gastric Cancer AJCC v8; Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8; Clinical Stage IIA Gastric Cancer AJCC v8; Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8; Clinical Stage IIB Gastric Cancer AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage IV Esophageal Adenocarcinoma AJCC v8; Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8; Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8; Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; Hepatobiliary Neoplasm; Malignant Digestive System Neoplasm; Malignant Female Reproductive System Neoplasm; Malignant Genitourinary System Neoplasm; Malignant Neoplasm; Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8; Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage 0 Gastric Cancer AJCC v8; Pathologic Stage I Esophageal Adenocarcinoma AJCC v8; Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage I Gastric Cancer AJCC v8; Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage IA Gastric Cancer AJCC v8; Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage IB Gastric Cancer AJCC v8; Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8; Pathologic Stage II Esophageal Adenocarcinoma AJCC v8; Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage II Gastric Cancer AJCC v8; Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage IIA Gastric Cancer AJCC v8; Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage IIB Gastric Cancer AJCC v8; Pathologic Stage III Esophageal Adenocarcinoma AJCC v8; Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage III Gastric Cancer AJCC v8; Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage IIIA Gastric Cancer AJCC v8; Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage IIIB Gastric Cancer AJCC v8; Pathologic Stage IIIC Gastric Cancer AJCC v8; Pathologic Stage IV Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage IV Gastric Cancer AJCC v8; Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8; Pathologic Stage IVB Esophageal Adenocarcinoma AJCC v8; Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8; Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8; Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8; Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8; Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8; Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8; Postneoadjuvant Therapy Stage IVB Esophageal Adenocarcinoma AJCC v8; Postneoadjuvant Therapy Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8; Stage 0 Colorectal Cancer AJCC v8; Stage 0a Bladder Cancer AJCC v8; Stage 0is Bladder Cancer AJCC v8; Stage I Bladder Cancer AJCC v8; Stage I Cervical Cancer AJCC v8; Stage I Colorectal Cancer AJCC v8; Stage I Ovarian Cancer AJCC v8; Stage I Prostate Cancer AJCC v8; Stage I Renal Cell Cancer AJCC v8; Stage I Uterine Corpus Cancer AJCC v8; Stage IA Cervical Cancer AJCC v8; Stage IA Ovarian Cancer AJCC v8; Stage IA Uterine Corpus Cancer AJCC v8; Stage IA1 Cervical Cancer AJCC v8; Stage IA2 Cervical Cancer AJCC v8; Stage IB Cervical Cancer AJCC v8; Stage IB Ovarian Cancer AJCC v8; Stage IB Uterine Corpus Cancer AJCC v8; Stage IB1 Cervical Cancer AJCC v8; Stage IB2 Cervical Cancer AJCC v8; Stage IC Ovarian Cancer AJCC v8; Stage II Bladder Cancer AJCC v8; Stage II Cervical Cancer AJCC v8; Stage II Colorectal Cancer AJCC v8; Stage II Ovarian Cancer AJCC v8; Stage II Prostate Cancer AJCC v8; Stage II Renal Cell Cancer AJCC v8; Stage II Uterine Corpus Cancer AJCC v8; Stage IIA Cervical Cancer AJCC v8; Stage IIA Colorectal Cancer AJCC v8; Stage IIA Ovarian Cancer AJCC v8; Stage IIA Prostate Cancer AJCC v8; Stage IIA1 Cervical Cancer AJCC v8; Stage IIA2 Cervical Cancer AJCC v8; Stage IIB Cervical Cancer AJCC v8; Stage IIB Colorectal Cancer AJCC v8; Stage IIB Ovarian Cancer AJCC v8; Stage IIB Prostate Cancer AJCC v8; Stage IIC Colorectal Cancer AJCC v8; Stage IIC Prostate Cancer AJCC v8; Stage III Bladder Cancer AJCC v8; Stage III Cervical Cancer AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Prostate Cancer AJCC v8; Stage III Renal Cell Cancer AJCC v8; Stage III Uterine Corpus Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8; Stage IIIA Cervical Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIA Ovarian Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIA Uterine Corpus Cancer AJCC v8; Stage IIIA1 Ovarian Cancer AJCC v8; Stage IIIA2 Ovarian Cancer AJCC v8; Stage IIIB Bladder Cancer AJCC v8; Stage IIIB Cervical Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIB Ovarian Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8; Stage IIIB Uterine Corpus Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IIIC Ovarian Cancer AJCC v8; Stage IIIC Prostate Cancer AJCC v8; Stage IIIC Uterine Corpus Cancer AJCC v8; Stage IIIC1 Uterine Corpus Cancer AJCC v8; Stage IIIC2 Uterine Corpus Cancer AJCC v8; Stage IV Bladder Cancer AJCC v8; Stage IV Cervical Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Prostate Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v8; Stage IV Uterine Corpus Cancer AJCC v8; Stage IVA Bladder Cancer AJCC v8; Stage IVA Cervical Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVA Uterine Corpus Cancer AJCC v8; Stage IVB Bladder Cancer AJCC v8; Stage IVB Cervical Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8; Stage IVB Uterine Corpus Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8
NCT04502602

Not yet recruiting

Niraparib and Neratinib in Advanced Solid Tumors With Expansion Cohort in Advanced Ovarian Cancer

Conditions: Advanced Solid Tumor; Ovarian Cancer
NCT04502836

Not yet recruiting

Evaluation of the Correlation Between Psychological Intervention, Including Providing Knowledge and Tools for Problems Solving, and the Anxiety Level of Female Patients Arriving to ACTH LRH Test - Pilot Study

Conditions: Precocious Puberty
NCT04498117

Not yet recruiting

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Conditions: Carcinoma, Ovarian Epithelial; Ovarian Neoplasms; Ovarian Cancer; Ovarian Serous Adenocarcinoma; Fallopian Tube Neoplasms; Fallopian Tube Adenocarcinoma; Fallopian Tube Serous Adenocarcinoma; Peritoneal Cancer; Peritoneal Carcinoma; Peritoneal Neoplasms
NCT04498520

Not yet recruiting

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Conditions: Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Hormone Receptor Positive Breast Carcinoma; Locally Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Metastatic Endometrioid Adenocarcinoma; Metastatic Fallopian Tube Carcinoma; Metastatic HER2 Negative Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Ovarian Carcinoma; Metastatic Primary Peritoneal Carcinoma; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Refractory Breast Carcinoma; Stage IV Fallopian Tube Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Primary Peritoneal Cancer AJCC v8; Stage IV Uterine Corpus Cancer AJCC v8; Stage IVA Fallopian Tube Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVA Primary Peritoneal Cancer AJCC v8; Stage IVA Uterine Corpus Cancer AJCC v8; Stage IVB Fallopian Tube Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Stage IVB Primary Peritoneal Cancer AJCC v8; Stage IVB Uterine Corpus Cancer AJCC v8
NCT04494945

Not yet recruiting

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Conditions: Hereditary Breast and Ovarian Cancer Syndrome; Hereditary Neoplastic Syndrome; Lynch Syndrome
NCT04491942

Not yet recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Conditions: Advanced Bile Duct Carcinoma; Advanced Breast Carcinoma; Advanced Cervical Carcinoma; Advanced Endometrial Carcinoma; Advanced Esophageal Carcinoma; Advanced Gastric Carcinoma; Advanced Head and Neck Carcinoma; Advanced Lung Non-Small Cell Carcinoma; Advanced Lung Small Cell Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Penile Carcinoma; Advanced Pleural Malignant Mesothelioma; Advanced Urothelial Carcinoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage IV Gastric Cancer AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVB Gastric Cancer AJCC v8; Pathologic Stage III Gastric Cancer AJCC v8; Pathologic Stage IIIA Gastric Cancer AJCC v8; Pathologic Stage IIIB Gastric Cancer AJCC v8; Pathologic Stage IIIC Gastric Cancer AJCC v8; Pathologic Stage IV Gastric Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8; Stage III Cervical Cancer AJCC v8; Stage III Distal Bile Duct Cancer AJCC v8; Stage III Intrahepatic Bile Duct Cancer AJCC v8; Stage III Lung Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Penile Cancer AJCC v8; Stage III Pleural Malignant Mesothelioma AJCC v8; Stage IIIA Cervical Cancer AJCC v8; Stage IIIA Distal Bile Duct Cancer AJCC v8; Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIA Ovarian Cancer AJCC v8; Stage IIIA Penile Cancer AJCC v8; Stage IIIA Pleural Malignant Mesothelioma AJCC v8; Stage IIIA1 Ovarian Cancer AJCC v8; Stage IIIA2 Ovarian Cancer AJCC v8; Stage IIIB Cervical Cancer AJCC v8; Stage IIIB Distal Bile Duct Cancer AJCC v8; Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIB Ovarian Cancer AJCC v8; Stage IIIB Penile Cancer AJCC v8; Stage IIIB Pleural Malignant Mesothelioma AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IIIC Ovarian Cancer AJCC v8; Stage IV Cervical Cancer AJCC v8; Stage IV Distal Bile Duct Cancer AJCC v8; Stage IV Intrahepatic Bile Duct Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Penile Cancer AJCC v8; Stage IV Pleural Malignant Mesothelioma AJCC v8; Stage IVA Cervical Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVA Ovarian Cancer AJCC v8; Stage IVB Cervical Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8; Stage IVB Ovarian Cancer AJCC v8; Triple-Negative Breast Carcinoma; Unresectable Urothelial Carcinoma
NCT04492553

Not yet recruiting

Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality

Conditions: Hypogonadism
NCT04493619

Not yet recruiting

PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer

Conditions: Gynecologic Neoplasms; Epithelial Ovarian Cancer
NCT04493788

Not yet recruiting

Molecular Basis of PCOS in Oocytes and Surrounding Cells

Conditions: Polycystic Ovary Syndrome
NCT04490915

Recruiting

Global Safety and Efficacy Registration Study of Crinecerfont for Congenital Adrenal Hyperplasia

Conditions: Congenital Adrenal Hyperplasia
NCT04489706

Recruiting

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Conditions: Ovarian Cancer; Endometrial Cancer
NCT04489979

Recruiting

Analgetics vs Analgetics and Antibiotics for Pediatric Clinical and Sonographic Orchitis or Epididymitis

Conditions: Epididymitis Orchitis
NCT04485403

Enrolling by invitation

The Effect of Ibuprofen on Women With PCOS.

Conditions: PCOS; Hyperandrogenism; Inflammation
NCT04482309

Not yet recruiting

A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors

Conditions: Bladder Cancer, Biliary Tract Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer, Pancreatic Cancer, Rare Tumors
NCT04475744

Not yet recruiting

4-step ASCOT in POI Women to Promote Follicular Rescue

Conditions: Premature Ovarian Insufficiency
NCT04473339

Not yet recruiting

A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

Conditions: Ovarian Cancer; Epithelial Ovarian Cancer; Ovarian Cancer, Epithelial; Hyperthermic Intraperitoneal Chemotherapy(HIPEC); Homologous Recombination Repair Gene Mutation
NCT04473833

Recruiting

Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

Conditions: Ovarian Cancer
NCT04470921

Enrolling by invitation

STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands

Conditions: Risk Reduction; Ovarian Cancer
NCT04471012

Completed

The Transtheoretical Model For Polycystic Ovary Syndrome

Conditions: Polycystic Ovary Syndrome
NCT04467697

Completed

Ambulatory Blood Pressure Monitoring (ABPM) Extension Study of Oral Testosterone Undecanoate in Hypogonadal Men

Conditions: Hypogonadism, Male
NCT04463316

Recruiting

GROWing Up With Rare GENEtic Syndromes

Conditions: Prader-Willi Syndrome; PWS-like Syndrome; Silver Russel Syndrome; Congenital Hypopituitarism; Klinefelter (XXY-)Syndrome; Congenital Adrenal Hyperplasia; XXXXY Syndrome; XXYY Syndrome; XXXX Syndrome (Tetra-X Syndrome); Disorders of Sex Development; Turner Syndrome; 46, XY DSD; Tuberous Sclerosis; Neurofibromatosis; Albright Hereditaire Osteodystrofie; Cornelia de Lange Syndrome; Saethre-Chotzen Syndrome; 17p- Deletiesyndrome; VCF Syndrome; POLR3A Mutatie; Ohdo Syndrome; Jacobsen Syndrome / 11 q Syndrome; Myrhe Syndrome; CHARGE Syndrome; 1q25-32 Deletie; Bardet Biedl Syndrome; Rett Syndrome; 22q11 Deletion Syndrome; Allan-Herndon-Dudley Syndrome; Kallmann Syndrome; Rare Bone Disorders; Noonan Syndrome; Williams-Beuren Syndrome
NCT04464967

Not yet recruiting

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Conditions: Advanced Solid Tumor; Metastatic Cancer; HER2-positive Breast Cancer; HER2-positive Gastric Cancer; HER-2 Protein Overexpression; Esophageal Cancer; Ovarian Cancer; Endometrium Cancer; Bladder Cancer; Pancreatic Cancer; Colorectal Cancer; Non Small Cell Lung Cancer; EGF-R Positive Non-Small Cell Lung Cancer; Head and Neck Squamous Cell Carcinoma; Triple Negative Breast Cancer; Cervical Cancer; Sarcoma
NCT04460768

Recruiting

An INternational Frontline Ovarian Cancer Real World Management Study

Conditions: Ovarian Neoplasms
NCT04460807

Recruiting

Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer

Conditions: Ovarian Cancer
NCT04460872

Not yet recruiting

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Conditions: Spinal Cord Injury; Spinal Cord Injuries; Trauma, Nervous System; Wounds and Injury; Central Nervous System Diseases; Spinal Cord Diseases; Gonadal Disorders; Endocrine System Diseases; Hypogonadism; Genital Diseases, Male; Spinal Cord Trauma; Injuries, Spinal Cord; Walking, Difficulty; Gait Disorders, Neurologic; Locomotion Disorder, Neurologic; Wounds and Injuries; Nervous System Diseases; Testosterone Deficiency; Androgen Deficiency; Hormone Deficiency
NCT04461457

Completed

Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2

Conditions: Ovarian Cancer
NCT04457089

Not yet recruiting

Statin Therapy to Reduce Progression in Women With Platinum Sensitive Ovarian Cancer

Conditions: Recurrent Ovarian Cancer; Platinum-sensitive Ovarian Cancer
NCT04457336

Recruiting

A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

Conditions: Congenital Adrenal Hyperplasia
NCT04458597

Not yet recruiting

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

Conditions: Endometrioid Adenocarcinoma; Serous Carcinoma; Clear Cell Carcinoma; Carcinosarcoma; Dedifferentiated Carcinoma
NCT04459273

Not yet recruiting

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Conditions: Bladder Carcinoma; Cervical Carcinoma; Cholangiocarcinoma; Hematopoietic and Lymphoid Cell Neoplasm; Hepatocellular Carcinoma; Malignant Adrenal Gland Neoplasm; Malignant Brain Neoplasm; Malignant Pleural Neoplasm; Malignant Skin Neoplasm; Malignant Solid Neoplasm; Malignant Testicular Neoplasm; Malignant Thymus Neoplasm; Neuroendocrine Neoplasm; Thyroid Gland Carcinoma; Urothelial Carcinoma
NCT04456296

Recruiting

A Study of the Effect of Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With Hypogonadism

Conditions: Hypogonadism; Hypogonadism, Male; Hypogonadotropic Hypogonadism
NCT04452968

Recruiting

Comparison of Intermittent Fasting and Caloric Deficit for Weight Loss in Women With Polycystic Ovarian Syndrome

Conditions: Polycystic Ovarian Syndrome; Weight Loss; Intermittent Fasting
NCT04453306

Recruiting

Treatment of Obesity With Topiramate in Patients With Polycystic Ovary Syndrome

Conditions: Obesity; Polycystic Ovary Syndrome; Hyperandrogenism
NCT04454450

Recruiting

Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

Conditions: Ovarian Cancer; High Grade Ovarian Serous
NCT04451369

Not yet recruiting

Connected Prehabilitation Program During Neo Adjuvant Chemotherapy

Conditions: Ovarian Cancer
NCT04448730

Completed

Polycystic Ovary Syndrome and BETATROPHIN

Conditions: Polycystic Ovary; Obesity
NCT04438564

Recruiting

Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients

Conditions: Breast Cancer; Colorectal Cancer; Cancer of Ovary; Cancer of Endometrium
NCT04439370

Recruiting

Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women

Conditions: Hypertension; Menopause, Premature; Menopause; Blood Pressure
NCT04439799

Not yet recruiting

A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections

Conditions: Hypogonadism, Male
NCT04435756

Recruiting

A Study of miRNA 371 in Patients With Germ Cell Tumors

Conditions: Germ Cell Tumor; Metachronous Malignant Neoplasm; Seminoma; Stage I Testicular Cancer AJCC v8; Stage IA Testicular Cancer AJCC v8; Stage IB Testicular Cancer AJCC v8; Stage IS Testicular Cancer AJCC v8
NCT04429542

Recruiting

Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors

Conditions: TNBC - Triple-Negative Breast Cancer; Head and Neck Squamous Cell Carcinoma; Squamous Cell Carcinoma of Anal Canal; Uveal Melanoma; Glioblastoma; Colorectal Cancer; Chordoma; Squamous Cell Carcinoma of the Lung; KRAS G12D; KRAS G13D; EGFR Amplification; Epithelial Ovarian Cancer; Hepatocellular Carcinoma; Anaplastic Thyroid Cancer; Pancreas Cancer
NCT04425083

Completed

Relationship of the Chinese Medical Constitution & Syndromes in Patients With Polycystic Ovary Syndrome

Conditions: Polycystic Ovary Syndrome
NCT04428827

Recruiting

Outcome of Patients With Primary Aldosteronism

Conditions: Primary Aldosteronism; Primary Aldosteronism Due to Aldosterone Producing Adenoma; Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral); Adrenalectomy; Status; Mineralocorticoid Excess; Mineralocorticoid Antagonists [Aldosterone Antagonists] Causing Adverse Effects in Therapeutic Use; Cardiovascular Morbidity; Chronic Renal Disease; Hypokalemia
NCT04421547

Not yet recruiting

Efficacy of Letrozole in Recurrent Ovarian Cancer

Conditions: Epithelial Ovarian Cancer
NCT04414683

Recruiting

Factors Affecting the Prognosis of Early Ovarian Cancer

Conditions: Ovarian Cancer
NCT04415944

Recruiting

Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy

Conditions: Ovarian Epithelial Cancer Stage I; Ovarian Epithelial Cancer Stage II; Ovarian Epithelial Cancer Stage III; Stage I Fallopian Tube Cancer; Stage II Fallopian Tube Cancer; Stage III Fallopian Tube Cancer; Peritoneal Carcinoma
NCT04416620

Completed

The Impact of a Pharmaceutical Care Model on Improving Polycystic Ovary Syndrome

Conditions: Polycystic Ovary Syndrome
NCT04417192

Not yet recruiting

Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer

Conditions: Ovarian Cancer